Literature DB >> 6662144

What is the association of essential fatty acid status with cystic fibrosis?

V S Hubbard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6662144     DOI: 10.1007/bf00496792

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  17 in total

1.  Abnormal fatty acid composition and impaired oxygen supply in cystic fibrosis patients.

Authors:  I M Campbell; D N Crozier; R B Caton
Journal:  Pediatrics       Date:  1976-04       Impact factor: 7.124

2.  Essential fatty acid status in cystic fibrosis and the effects of safflower oil supplementation.

Authors:  J D Lloyd-Still; S B Johnson; R T Holman
Journal:  Am J Clin Nutr       Date:  1981-01       Impact factor: 7.045

3.  Fibroblast fatty acids in cystic fibrosis.

Authors:  H P Chase; C S Dabiere; R B Elliott
Journal:  Metabolism       Date:  1980-04       Impact factor: 8.694

4.  Effectiveness of cimetidine as an adjunct to supplemental pancreatic enzymes in patients with cystic fibrosis.

Authors:  V S Hubbard; G D Dunn; L A Lester
Journal:  Am J Clin Nutr       Date:  1980-11       Impact factor: 7.045

Review 5.  Cystic fibrosis and malnutrition.

Authors:  H P Chase; M A Long; M H Lavin
Journal:  J Pediatr       Date:  1979-09       Impact factor: 4.406

6.  Energy intake and nutrition counseling in cystic fibrosis.

Authors:  V S Hubbard; P J Mangrum
Journal:  J Am Diet Assoc       Date:  1982-02

7.  Plasma membrane lipids of human diploid fibroblasts from normal individuals and patients with cystic fibrosis.

Authors:  J R Riordan; N Alon; M Buchwald
Journal:  Biochim Biophys Acta       Date:  1979-07-27

8.  Oral correction of essential fatty acid deficiency in cystic fibrosis.

Authors:  C Landon; J A Kerner; R Castillo; L Adams; R Whalen; N J Lewiston
Journal:  JPEN J Parenter Enteral Nutr       Date:  1981 Nov-Dec       Impact factor: 4.016

9.  Abnormal fatty-acid composition of plasma-lipids in cystic fibrosis. A primary or a secondary defect?

Authors:  V S Hubbard; G D Dunn; P A di Sant'Agnese
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

10.  Linoleic acid absorption in children with cystic fibrosis.

Authors:  H P Chase; N N Welch; M E Rabaglia; J Dupont
Journal:  J Pediatr Gastroenterol Nutr       Date:  1982       Impact factor: 2.839

View more
  7 in total

Review 1.  Cystic fibrosis--a gastroenterological cornucopia.

Authors:  P L Zentler-Munro
Journal:  Gut       Date:  1987-11       Impact factor: 23.059

2.  Fatty acid pattern of platelet phospholipids in cystic fibrosis.

Authors:  V Rogiers; A Vercruysse; I Dab; R Crokaert; H L Vis
Journal:  Eur J Pediatr       Date:  1984-09       Impact factor: 3.183

3.  Relationships between essential fatty acid levels, pulmonary function and fat absorption in pre-adolescent cystic fibrosis children with good clinical scores.

Authors:  G N Thompson
Journal:  Eur J Pediatr       Date:  1989-01       Impact factor: 3.183

4.  Serum linoleic acid status as a clinical indicator of essential fatty acid status in children with cystic fibrosis.

Authors:  Asim Maqbool; Joan I Schall; J Felipe Garcia-Espana; Babette S Zemel; Birgitta Strandvik; Virginia A Stallings
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-11       Impact factor: 2.839

5.  Absorption of safflower oil and structured lipid preparations in patients with cystic fibrosis.

Authors:  V S Hubbard; M C McKenna
Journal:  Lipids       Date:  1987-06       Impact factor: 1.880

Review 6.  Human milk in disease: lipid composition.

Authors:  M Hamosh; J Bitman
Journal:  Lipids       Date:  1992-11       Impact factor: 1.880

7.  Absorption of triglycerides with defined or random structure by rats with biliary and pancreatic diversion.

Authors:  M S Christensen; A Müllertz; C E Høy
Journal:  Lipids       Date:  1995-06       Impact factor: 1.880

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.